1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1:

Patient demographic and clinical data

Pediatric Patients (n = 24)Adult Patients (n = 20)
Age (mean) (yr)9.21 ± 3.5932.4 ± 10.94
Sex (male) (No.) (%)16 (67)3 (15)
Clinical presentation (No.) (%)
    Focal neurologic symptoms17 (71)13 (65)
    Seizure3 (13)4 (20)
    Headache5 (21)3 (15)
    Infarction9 (38)14 (70)
    Hemorrhage0 (0)1 (5)
Comorbidities (No.) (%)a3 (8)0 (0)
  • a There were 2 patients with neurofibromatosis type 1 and 1 patient with systemic lupus erythematosus.